These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33042403)

  • 1. Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice.
    Han P; Weng W; Chen Y; Cai Y; Wang Y; Wang M; Zhan H; Yuan C; Yu X; Shao M; Sun H
    Am J Transl Res; 2020; 12(9):5015-5031. PubMed ID: 33042403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niclosamide ethanolamine protects kidney in adriamycin nephropathy by regulating mitochondrial redox balance.
    Han P; Yuan C; Wang Y; Wang M; Weng W; Zhan H; Yu X; Wang T; Li Y; Yi W; Shao M; Li S; Yi T; Sun H
    Am J Transl Res; 2019; 11(2):855-864. PubMed ID: 30899385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J; Sun M; Tian S
    Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation.
    Wang H; Shen M; Ma Y; Lan L; Jiang X; Cen X; Guo G; Zhou Q; Yuan M; Chen J; Xia H; Xiao L; Han F
    Kidney Int; 2024 Apr; 105(4):759-774. PubMed ID: 38296028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K; Maeda Y; Shimano K; Murase M; Mochiduki S; Takemoto K; Kakimoto T; Utsumi H; Oshita K; Kataoka H
    J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B; Ye H; You X; Ni H; Chen X; Li L
    Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z; Liu D; Zhang X; Wang X
    Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of USF2 inhibits pyroptosis of podocytes and attenuates kidney injury in lupus nephritis.
    Xie Y; Li X; Deng W; Nan N; Zou H; Gong L; Chen M; Yu J; Chen P; Cui D; Zhang F
    J Mol Histol; 2023 Aug; 54(4):313-327. PubMed ID: 37341818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALW peptide ameliorates lupus nephritis in MRL/lpr mice.
    Wang H; Lu M; Zhai S; Wu K; Peng L; Yang J; Xia Y
    Arthritis Res Ther; 2019 Dec; 21(1):261. PubMed ID: 31791413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
    Wu X; Guo J; Ding R; Lv B; Bi L
    Acta Histochem; 2015 Oct; 117(8):732-7. PubMed ID: 26456520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologic role for enhanced renal thromboxane production in murine lupus nephritis.
    Spurney RF; Bernstein RJ; Ruiz P; Pisetsky DS; Coffman TM
    Prostaglandins; 1991 Jul; 42(1):15-28. PubMed ID: 1771236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
    Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
    Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
    Renner K; Hermann FJ; Schmidbauer K; Talke Y; Rodriguez Gomez M; Schiechl G; Schlossmann J; Brühl H; Anders HJ; Mack M
    Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice.
    Nakatani K; Yoshimoto S; Asai O; Sakan H; Terada M; Saito Y; Nose M; Iwano M; Konishi N
    Immun Inflamm Dis; 2013 Oct; 1(1):37-46. PubMed ID: 25400916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
    Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.